Items where Author is "Mirian, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 60.

Article

(2025) Co-delivery of dasatinib and miR-30a by liposomes targeting neuropilin-1 receptors for triple-negative breast cancer therapy. Journal of materials chemistry. B. pp. 1794-1810. ISSN 2050-7518 (Electronic) 2050-750X (Linking)

(2025) Comparing the transfection efficiency of cationic monomer ratios in vinylimidazole and aminoethyl methacrylate copolymers. International Journal of Pharmaceutics-X. p. 13.

(2025) Synthesis and in vitro evaluation of self-assembling biocompatible heparin-based targeting polymeric micelles for delivery of doxorubicin to leukemic cells. Research in Pharmaceutical Sciences. pp. 142-164. ISSN 1735-5362

(2024) Biocompatible nanocomposite scaffolds based on carrageenan incorporating hydroxyapatite and hesperidin loaded nanoparticles for bone tissue regeneration. Polymers for Advanced Technologies. p. 19. ISSN 1042-7147

(2024) Co-delivery of Interferon Regulatory Factor 5 (IRF5) siRNA and dasatinib by a disulfide bond bearing polymeric carrier for enhanced anti-inflammatory effects. International Journal of Biological Macromolecules. p. 19. ISSN 0141-8130

(2024) Co-delivery of dasatinib and miR-30a by liposomes targeting neuropilin-1 receptors for triple-negative breast cancer therapy. Journal of Materials Chemistry B. pp. 1794-1810. ISSN 2050750X (ISSN)

(2024) Hypoxia-preconditioned WJ-MSC spheroid-derived exosomes delivering miR-210 for renal cell restoration in hypoxia-reoxygenation injury. Stem Cell Research & Therapy. p. 15.

(2024) Intersecting pathways: The role of hybrid E/M cells and circulating tumor cells in cancer metastasis and drug resistance. Drug Resistance Updates. p. 15. ISSN 1368-7646

(2024) Keratinocyte Exosomes for Topical Delivery of Tofacitinib in Treatment of Psoriasis: an In Vitro/ In Vivo Study in Animal Model of Psoriasis. Pharmaceutical Research. pp. 263-279. ISSN 0724-8741

(2024) MicroRNA-219 in the central nervous system: a potential theranostic approach. Research in Pharmaceutical Sciences. pp. 634-655. ISSN 1735-5362

(2024) Pepgen-P15 delivery to bone: A novel 3D printed scaffold for enhanced bone regeneration. Journal of Drug Delivery Science and Technology. p. 15. ISSN 1773-2247

(2024) Spirulina protein concentrate hydrogel reinforced by hydroxyapatite nanoparticles and hydroxychloroquin: A novel platform for bone regeneration. Materials Today Communications. p. 15.

(2024) Targeted delivery of liposomal Ribociclib to SLC7A5 transporters in breast cancer cells. Investigational new drugs. pp. 89-105. ISSN 1573-0646 (Electronic) 0167-6997 (Linking)

(2024) Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance. Cancer metastasis reviews. pp. 363-377. ISSN 1573-7233 (Electronic) 0167-7659 (Linking)

(2024) A forsterite-reinforced polypropylene fumarate/methoxy polyethylene glycol-hydrogel enriched with flavonoid nanoparticles enhances osteoconductivity. Materials Advances. pp. 4324-4344.

(2023) Anderson-type manganese polyoxomolybdate hybrid nanocomposite for boosting drug delivery against breast cancer. Journal of Drug Delivery Science and Technology. p. 13. ISSN 1773-2247

(2023) Bio-Membrane SELEX as a New Approach for Selecting ss-DNA Aptamers that Bind to the Hydatid Cyst Laminated Layer. Current Molecular Medicine. pp. 578-587. ISSN 1566-5240

(2023) CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer. European Journal of Cell Biology. p. 18. ISSN 0171-9335

(2023) Crosstalk of Transcriptional Regulators of Adaptive Immune System and microRNAs: An Insight into Differentiation and Development. Cells. p. 23.

(2023) Exosomes as efficient platforms for delivering adenosine-tetra peptide conjugate to pancreatic cancer cells: An <i>in vitro/in silico</i> study. Journal of Drug Delivery Science and Technology. p. 14. ISSN 1773-2247

(2023) Fabrication and evaluation of a dual-targeting nanoparticle mediated CRISPR/Cas9 delivery to combat drug resistance in breast cancer cells. Journal of Drug Delivery Science and Technology. p. 15. ISSN 1773-2247

(2023) Gene network analysis of oxaliplatin-resistant colorectal cancer to target a crucial gene using chitosan/hyaluronic acid/protamine polyplexes containing CRISPR-Cas9. Biochimica Et Biophysica Acta-General Subjects. p. 12. ISSN 0304-4165

(2023) Hyaluronic acid-conjugated gliadin nanoparticles for targeted delivery of usnic acid in breast cancer: An <i>in vitro</i>/<i>in vivo</i> translational study. Journal of Drug Delivery Science and Technology. p. 11. ISSN 1773-2247

(2023) Investigation of Biological Effects of New Tetrazole Compounds on Cancer Cell Lines (HeLa, MCF-7) and Common Microorganisms (Staphylococcus Aureus, Escherichia Coli, Candida Albicans). Journal of Isfahan Medical School. pp. 18-26. ISSN 10277595 (ISSN)

(2023) Peptide-based pegylated polyurethane nanoparticles for paclitaxel delivery in HeLa cancer cells: the art of the architecture design in nanocarriers. Polymer Bulletin. pp. 10493-10531. ISSN 01700839 (ISSN)

(2023) Smart redox-sensitive micelles based on chitosan for dasatinib delivery in suppressing inflammatory diseases. International Journal of Biological Macromolecules. pp. 696-712. ISSN 0141-8130

(2023) Thermosensitive TMPO-oxidized lignocellulose/cationic agarose hydrogel loaded with deferasirox nanoparticles for photothermal therapy in melanoma. International Journal of Biological Macromolecules. p. 13. ISSN 0141-8130

(2023) The circadian rhythm: an influential soundtrack in the diabetes story. Frontiers in Endocrinology. p. 17. ISSN 1664-2392

(2022) Bio-Membrane SELEX as a new approach for selecting ss-DNA aptamers that bind to the hydatid cyst laminated layer. Curr Mol Med. ISSN 1566-5240

(2022) Circadian and Immunity Cycle Talk in Cancer Destination: From Biological Aspects to In Silico Analysis. CANCERS. ISSN 2072-6694 J9 - CANCERS

(2022) Design, synthesis, and cytotoxicity evaluation of novel indole-acylhydrazone derivatives of 4-pyridinone as potential histone deacetylase-2 inhibitors. Research in Pharmaceutical Sciences. pp. 572-584. ISSN 1735-5362

(2022) Evaluation of thermosensitive chitosan hydrogel containing gefitinib loaded cellulose acetate butyrate nanoparticles in a subcutaneous breast cancer model. Int J Pharm. p. 122036. ISSN 0378-5173

(2022) Evolocumab, a PCSK9 inhibitor, protects human endothelial cells against H(2)O(2)-induced oxidative stress. Archives of Physiology and Biochemistry. pp. 1681-1686. ISSN 1744-4160 (Electronic) 1381-3455 (Linking)

(2022) Expression of recombinant insulin-like growth factor-binding protein-3 receptor in mammalian cell line and prokaryotic (<i>Escherichia coli</i>) expression systems. Advanced Biomedical Research. p. 8. ISSN 2277-9175

(2022) Expression of recombinant insulin-like growth factor-binding protein-3 receptor in mammalian cell line and prokaryotic (Escherichia coli) expression systems. ADVANCED BIOMEDICAL RESEARCH. ISSN 2277-9175 J9 - ADV BIOMED RES-INDIA

(2022) Fabrication and optimization of electrospun polymeric nanofibers loaded with 5-fluorouracil and rosemary extract. Pharm Nanotechnol. ISSN 2211-7385

(2022) Glutathione targeted tragacanthic acid-chitosan as a non-viral vector for brain delivery of miRNA-219a-5P: An in vitro/in vivo study. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. pp. 543-556. ISSN 0141-8130 1879-0003 J9 - INT J BIOL MACROMOL

(2022) Local delivery of usnic acid loaded Rhamnolipid vesicles by gelatin / tragacanth gum / montmorillonite/ vanillin cryogel scaffold for expression of osteogenic biomarkers and antimicrobial activity. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY. ISSN 1773-2247 2588-8943 J9 - J DRUG DELIV SCI TEC

(2022) Myrsinane-type diterpenes from <i>Euphorbia gedrosiaca</i> with cell growth inhibitory activity and apoptotic effects on melanoma cancer cells. Fitoterapia. p. 8. ISSN 0367-326X

(2022) Myrsinane-type diterpenes from Euphorbia gedrosiaca with cell growth inhibitory activity and apoptotic effects on melanoma cancer cells. FITOTERAPIA. ISSN 0367-326X 1873-6971 J9 - FITOTERAPIA

(2022) Redox responsive polymeric micelles of gellan gum/abietic acid for targeted delivery of ribociclib. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. pp. 334-345. ISSN 0141-8130 1879-0003 J9 - INT J BIOL MACROMOL

(2022) Thermo-responsive hydrogels based on methylcellulose/Persian gum loaded with taxifolin enhance bone regeneration: an in vitro/in vivo study. CELLULOSE. pp. 2413-2433. ISSN 0969-0239 1572-882X J9 - CELLULOSE

(2022) pH-responsive glucosamine anchored polydopamine coated mesoporous silica nanoparticles for delivery of Anderson-type polyoxomolybdate in breast cancer. J Microencapsul. pp. 1-19. ISSN 0265-2048

(2021) 4-Hydroxyhalcone effects on cisplatin-induced genotoxicity model. Toxicology Research. pp. 11-17. ISSN 2045-452X

(2021) Boron phenyl alanine targeted chitosan-PNIPAAm core-shell thermo-responsive nanoparticles: boosting drug delivery to glioblastoma in BNCT. Drug Dev Ind Pharm. pp. 1607-1623. ISSN 0363-9045

(2021) Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells. Journal of Liposome Research. pp. 64-78. ISSN 0898-2104

(2021) Effect of bassorin (derived from gum tragacanth) and halloysite nanotubes on physicochemical properties and the osteoconductivity of methylcellulose-based injectable hydrogels. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. pp. 869-882. ISSN 0141-8130 1879-0003 J9 - INT J BIOL MACROMOL

(2021) Fabrication and characterization of injectable thermosensitive hydrogel containing dipyridamole loaded polycaprolactone nanoparticles for bone tissue engineering. Journal of Drug Delivery Science and Technology. ISSN 17732247 (ISSN)

(2021) Generation of HBsAg DNA aptamer using modified cell-based SELEX strategy. Molecular Biology Reports. pp. 139-146. ISSN 0301-4851

(2021) Holothurin B Isolated from Holothuria atra Inhibits Angiogenesis More Potent than Curcumin in Vitro. Research Journal of Pharmacognosy. pp. 33-40. ISSN 2345-4458

(2021) The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy. International Journal of Molecular Sciences.

(2021) Pegylated multifunctional pH-responsive targeted polymeric micelles for ovarian cancer therapy: synthesis, characterization and pharmacokinetic study. International Journal of Polymeric Materials and Polymeric Biomaterials. pp. 1012-1026. ISSN 0091-4037

(2021) Simvastatin nanosuspensions prepared using a combination of pH-sensitive and timed-release approaches for potential treatment of colorectal cancer. Pharmaceutical Development and Technology. pp. 335-348. ISSN 1083-7450

(2016) Antiproliferative effect of a synthetic aptamer mimicking androgen response elements in the LNCaP cell line. Cancer Gene Therapy. pp. 254-257. ISSN 0929-1903

(2016) Exposition of hepatitis B surface antigen (HBsAg) on the surface of HEK293T cell and evaluation of its expression. Research in Pharmaceutical Sciences. pp. 366-373. ISSN 1735-5362

(2016) Targeted delivery of doxorubicin to breast cancer cells by magnetic LHRH chitosan bioconjugated nanoparticles. International Journal of Biological Macromolecules. pp. 1192-1205. ISSN 0141-8130

(2015) Cytotoxic evaluation of volatile oil from Descurainia sophia seeds on MCF-7 and HeLa cell lines. Research in Pharmaceutical Sciences. pp. 169-176. ISSN 1735-5362

(2015) Cytotoxicity and antiangiogenic effects of Rhus coriaria, Pistacia vera and Pistacia khinjuk oleoresin methanol extracts. Research in Pharmaceutical Sciences. pp. 233-240. ISSN 1735-5362

(2015) Investigation of Astragalus honey and propolis extract's cytotoxic effect on two human cancer cell lines and their oncogen and proapoptotic gene expression profiles. Advanced biomedical research. p. 42. ISSN 2277-9175 (Print) 2277-9175 (Linking)

(2015) Methotrexate-grafted-oligochitosan micelles as drug carriers: synthesis and biological evaluations. Journal of Materials Science-Materials in Medicine. ISSN 0957-4530

This list was generated on Sat May 31 23:41:52 2025 +0330.